New Guidelines on Pharmacologic Treatment of Obesity: Clinical Pearls from Dr. Neil Skolnik

Experts share the latest updates on the Standards of Care in Overweight and Obesity

The growing document provides evidence-based, unified guidance and actionable recommendations. Leigh Perreault, MD, presented a new chapter

CME | Beyond Judgement: What Actually Works for Weight Loss?

In this episode of CME on the go, our hosts focus on discussing GLP-1 agonists and their impact on obesity management. They delve into patie

CME | Slim Solutions: Navigating Weight Loss Medications

The CME on the Go series of the Inside Family Medicine podcast lets you earn up to 0.5 CME credits per episode — join the hosts as they dive

New guideline highlights obesity’s central role in heart, kidney, and metabolic disease

Opinion: Who benefits from classifying obesity as a disease?

“The new wave of obesity pharmacotherapy has leaned heavily on disease framing,” writes Max Moser, drawing comparisons to the antidepressant

Study identifies patients with obesity most likely to benefit from GLP-1-based treatment

Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a p